Comment
doi: 10.1016/j.ijcard.2018.05.121.
How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
Affiliations
- PMID: 30223357
- DOI: 10.1016/j.ijcard.2018.05.121
Item in Clipboard
Comment
How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?
Int J Cardiol.
.
No abstract available
Keywords: Acute coronary syndrome; Antiplatelet therapy; Pharmacogenomic testing; Platelet function testing.
Comment in
-
Response to Letter of Li et al.: How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?Int J Cardiol. 2018 Nov 15;271:30. doi: 10.1016/j.ijcard.2018.06.048. Int J Cardiol. 2018. PMID: 30223360 No abstract available.
Comment on
-
High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.Int J Cardiol. 2018 May 15;259:20-25. doi: 10.1016/j.ijcard.2018.01.057. Int J Cardiol. 2018. PMID: 29579602
-
Relationship between CHA2DS2-VASc score, coronary artery disease severity, residual platelet reactivity and long-term clinical outcomes in patients with acute coronary syndrome.Int J Cardiol. 2018 Jul 1;262:9-13. doi: 10.1016/j.ijcard.2018.03.086. Epub 2018 Mar 20. Int J Cardiol. 2018. PMID: 29602582
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
